Literature DB >> 22442027

Nitric oxide-mediated central sympathetic excitation promotes CNS and pulmonary O₂ toxicity.

Ivan T Demchenko1, Alexander N Moskvin, Alexander I Krivchenko, Claude A Piantadosi, Barry W Allen.   

Abstract

In hyperbaric oxygen (HBO(2)) at or above 3 atmospheres absolute (ATA), autonomic pathways link central nervous system (CNS) oxygen toxicity to pulmonary damage, possibly through a paradoxical and poorly characterized relationship between central nitric oxide production and sympathetic outflow. To investigate this possibility, we assessed sympathetic discharges, catecholamine release, cardiopulmonary hemodynamics, and lung damage in rats exposed to oxygen at 5 or 6 ATA. Before HBO(2) exposure, either a selective inhibitor of neuronal nitric oxide synthase (NOS) or a nonselective NOS inhibitor was injected directly into the cerebral ventricles to minimize effects on the lung, heart, and peripheral circulation. Experiments were performed on both anesthetized and conscious rats to differentiate responses to HBO(2) from the effects of anesthesia. EEG spikes, markers of CNS toxicity in anesthetized animals, were approximately four times as likely to develop in control rats than in animals with central NOS inhibition. In inhibitor-treated animals, autonomic discharges, cardiovascular pressures, catecholamine release, and cerebral blood flow all remained below baseline throughout exposure to HBO(2). In control animals, however, initial declines in these parameters were followed by significant increases above their baselines. In awake animals, central NOS inhibition significantly decreased the incidence of clonic-tonic convulsions or delayed their onset, compared with controls. The novel findings of this study are that NO produced by nNOS in the periventricular regions of the brain plays a critical role in the events leading to both CNS toxicity in HBO(2) and to the associated sympathetic hyperactivation involved in pulmonary injury.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22442027      PMCID: PMC3379151          DOI: 10.1152/japplphysiol.00902.2011

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  42 in total

1.  Changes in nitric oxide production and cerebral blood flow before development of hyperbaric oxygen-induced seizures in rats.

Authors:  T Sato; Y Takeda; S Hagioka; S Zhang; M Hirakawa
Journal:  Brain Res       Date:  2001-11-09       Impact factor: 3.252

Review 2.  Role of nitric oxide in central sympathetic outflow.

Authors:  K P Patel; Y F Li; Y Hirooka
Journal:  Exp Biol Med (Maywood)       Date:  2001-10

3.  A role of nitric oxide as an inhibitor of gamma-aminobutyric acid transaminase in rat brain.

Authors:  V Paul; A R Jayakumar
Journal:  Brain Res Bull       Date:  2000-01-01       Impact factor: 4.077

4.  Autonomic activation links CNS oxygen toxicity to acute cardiogenic pulmonary injury.

Authors:  Ivan T Demchenko; S Yu Zhilyaev; A N Moskvin; Claude A Piantadosi; Barry W Allen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-10-22       Impact factor: 5.464

5.  Nitric oxide production is enhanced in rat brain before oxygen-induced convulsions.

Authors:  I T Demchenko; A E Boso; A R Whorton; C A Piantadosi
Journal:  Brain Res       Date:  2001-11-02       Impact factor: 3.252

6.  Hyperbaric oxygen reduces cerebral blood flow by inactivating nitric oxide.

Authors:  I T Demchenko; A E Boso; P B Bennett; A R Whorton; C A Piantadosi
Journal:  Nitric Oxide       Date:  2000-12       Impact factor: 4.427

7.  Effect of hyperbaric oxygen treatment on nitric oxide and oxygen free radicals in rat brain.

Authors:  I M Elayan; M J Axley; P V Prasad; S T Ahlers; C R Auker
Journal:  J Neurophysiol       Date:  2000-04       Impact factor: 2.714

8.  Role of GABA and NO in the paraventricular nucleus-mediated reflex inhibition of renal sympathetic nerve activity following stimulation of right atrial receptors in the rat.

Authors:  Zhuo Yang; John H Coote
Journal:  Exp Physiol       Date:  2003-05       Impact factor: 2.969

9.  Oxygen seizure latency and peroxynitrite formation in mice lacking neuronal or endothelial nitric oxide synthases.

Authors:  Ivan T Demchenko; Dmitriy N Atochin; Albert E Boso; Joshua Astern; Paul L Huang; Claude A Piantadosi
Journal:  Neurosci Lett       Date:  2003-06-19       Impact factor: 3.046

10.  Stimulation of perivascular nitric oxide synthesis by oxygen.

Authors:  Stephen R Thom; Donald Fisher; Jie Zhang; Veena M Bhopale; S Tsuyoshi Ohnishi; Yashige Kotake; Tomoko Ohnishi; Donald G Buerk
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-12-27       Impact factor: 4.733

View more
  5 in total

1.  Increased Antiseizure Effectiveness with Tiagabine Combined with Sodium Channel Antagonists in Mice Exposed to Hyperbaric Oxygen.

Authors:  Ivan T Demchenko; Sergei Yu Zhilyaev; Olga S Alekseeva; Alexander I Krivchenko; Claude A Piantadosi; Heath G Gasier
Journal:  Neurotox Res       Date:  2019-05-30       Impact factor: 3.911

2.  The intravenous perfluorocarbon emulsion Oxycyte does not increase hyperbaric oxygen-related seizures in a non-sedated swine model.

Authors:  Richard T Mahon; Aaron Hall; Michael Bodo; Charles Auker
Journal:  Eur J Appl Physiol       Date:  2013-09-06       Impact factor: 3.078

3.  Hyperoxia in intensive care, emergency, and peri-operative medicine: Dr. Jekyll or Mr. Hyde? A 2015 update.

Authors:  Sebastian Hafner; François Beloncle; Andreas Koch; Peter Radermacher; Pierre Asfar
Journal:  Ann Intensive Care       Date:  2015-11-19       Impact factor: 6.925

Review 4.  CNS function and dysfunction during exposure to hyperbaric oxygen in operational and clinical settings.

Authors:  Geoffrey E Ciarlone; Christopher M Hinojo; Nicole M Stavitzski; Jay B Dean
Journal:  Redox Biol       Date:  2019-03-09       Impact factor: 11.799

Review 5.  The O2-sensitive brain stem, hyperoxic hyperventilation, and CNS oxygen toxicity.

Authors:  Jay B Dean; Nicole M Stavitzski
Journal:  Front Physiol       Date:  2022-07-26       Impact factor: 4.755

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.